生境分析在恶性肿瘤影像组学中的研究进展

doi:10.3760/cma.j.cn371439-20240108-00049

国际肿瘤学杂志 ›› 2024, Vol. 51 ›› Issue (5): 292-297.doi: 10.3760/cma.j.cn371439-20240108-00049

生境分析在恶性肿瘤影像组学中的研究进展

傅旖, 马辰莺, 张露, 周菊英()

苏州大学附属第一医院放疗科，苏州 215006

收稿日期:2024-01-08 修回日期:2024-03-15 出版日期:2024-05-08 发布日期:2024-06-26
通讯作者: 周菊英，Email：zhoujuyingsy@163.com
基金资助:
国家自然科学基金(82373204);国家自然科学基金(81602792);江苏省高等学校基础科学（自然科学）研究项目(23KJB310023);江苏省妇幼保健科研项目(F202210);“十四五”江苏省医学重点学科(ZDXK202235);苏州大学放射医学与辐射防护国家重点实验室资助项目(GZK1202101);苏州市科技计划(SLT201920);苏州市“科教兴卫”青年科技项目(KJXW2020008)

Research progress of habitat analysis in radiomics of malignant tumors

Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying()

Department of Radiation Oncology， First Affiliated Hospital of Soochow University， Suzhou 215006， China

Received:2024-01-08 Revised:2024-03-15 Online:2024-05-08 Published:2024-06-26
Contact: Zhou Juying， Email：zhoujuyingsy@163.com
Supported by:
National Natural Science Foundation of China(82373204);National Natural Science Foundation of China(81602792);Jiangsu Provincial Higher Education Institutions General Program for Basic Sciences （Natural Sciences）(23KJB310023);Research Project of Maternal and Child Health in Jiangsu Province(F202210);"14th Five-Year Plan" Jiangsu Provincial Medical Key Discipline(ZDXK202235);Project of State Key Laboratory of Radiation Medicine and Protection of Soochow University(GZK1202101);Suzhou Science and Technology Plan(SLT201920);Suzhou City "Science and Education Promote Health" Youth Science and Technology Project(KJXW2020008)

摘要/Abstract

摘要：

目前，针对传统影像组学的研究已逐渐成熟，但是它通常将肿瘤视为一个整体，高通量数据往往产生于整个肿瘤区域，无法表达明确的空间异质性。为挖掘肿瘤内部潜在的生物学信息，实现个体化精准诊疗，生境分析技术应运而生。该新技术提供了一种识别肿瘤微环境的新思路，其在传统影像组学的基础上，将具有相似表征的肿瘤细胞群进行聚类，并据此将肿瘤分割为多个亚区域，让肿瘤研究不再受限于观察者对影像特征描述的主观差异，最理想化地得到肿瘤空间异质性信息。

关键词: 肿瘤, 肿瘤微环境, 影像组学, 机器学习

Abstract:

Nowadays， the research on traditional radiomics has gradually matured. However， it usually regards the tumor as a whole， and high-throughput data are often generated in the entire tumor region， which cannot express clear spatial heterogeneity. In order to explore the potential biological information within tumors and realize individualized precise diagnosis and treatment， habitat analysis technology emerges at the historic moment， which provides a new way of thinking to identify tumor microenvironment. On the basis of traditional radiomics， the tumor cell population with similar characteristics is clustered， and the tumor is segmented into multiple sub-regions. Therefore， the study of tumor is no longer limited by the subjective differences of observers in the description of imaging features， and the information of tumor spatial heterogeneity is ideally obtained.

Key words: Neoplasms, Tumor microenvironment, Radiomics, Machine learning

傅旖, 马辰莺, 张露, 周菊英. 生境分析在恶性肿瘤影像组学中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(5): 292-297.

Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

参考文献 29

[1]	Mayerhoefer ME, Materka A, Langs G, et al. Introduction to radiomics[J]. J Nucl Med, 2020, 61(4): 488-495. DOI: 10.2967/jnumed.118.222893.
[2]	Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features[J]. Radiology, 2021, 299(2): E256. DOI: 10.1148/radiol.2021219005. pmid: 33900879
[3]	Wu J, Gensheimer MF, Zhang NS, et al. Tumor subregion evolution-based imaging features to assess early response and predict prognosis in oropharyngeal cancer[J]. J Nucl Med, 2020, 61(3): 327-336. DOI: 10.2967/jnumed.119.230037.
[4]	Sala E, Mema E, Himoto Y, et al. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging[J]. Clin Radiol, 2017, 72(1): 3-10. DOI: 10.1016/j.crad.2016.09.013. pmid: 27742105
[5]	Fahridzadeh H, Chaudhury B, Scott JG, et al. Signal intensity analysis of ecological defined habitat in soft tissue sarcomas to predict metastasis development[C]// Proceedings Volume 9785, Medical Imaging 2016:Computer-Aided Diagnosis. San Diego: SPIE, 2016: 97851H. DOI: 10.1117/12.2216961.
[6]	何瀚志, 朱红, 王竞. 基于聚类分析的医学图像分割综述[J]. 中国科技信息, 2017 (15): 43, 46. DOI: 10.3969/j.issn.1001-8972.2017.15.013.
[7]	Lee DH, Park JE, Kim NY, et al. Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery[J]. Eur Radiol, 2022, 32(1): 497-507. DOI: 10.1007/s00330-021-08204-1.
[8]	Schmitz J, Schwab J, Schwenck J, et al. Decoding intratumoral heterogeneity of breast cancer by multiparametric in vivo imaging: a translational study[J]. Cancer Res, 2016, 76(18): 5512-5522. DOI: 10.1158/0008-5472.CAN-15-0642. pmid: 27466286
[9]	王微. 多模态磁共振定量评估早期宫颈癌组织学危险因素及复发风险分层的研究[D]. 长春: 吉林大学, 2023. DOI: 10.27162/d.cnki.gjlin.2023.000311.
[10]	Sun R, Limkin EJ, Vakalopoulou M, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study[J]. Lancet Oncol, 2018, 19(9): 1180-1191. DOI: 10.1016/S1470-2045(18)30413-3. pmid: 30120041
[11]	Jeong SY, Park JE, Kim N, et al. Hypovascular cellular tumor in primary central nervous system lymphoma is associated with treatment resistance: tumor habitat analysis using physiologic MRI[J]. AJNR Am J Neuroradiol, 2022, 43(1): 40-47. DOI: 10.3174/ajnr.A7351.
[12]	Beer L, Martin-Gonzalez P, Delgado-Ortet M, et al. Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer[J]. Eur Radiol, 2021, 31(6): 3765-3772. DOI: 10.1007/s00330-020-07560-8.
[13]	娄潇方, 范明, 许茂盛, 等. 基于多参数磁共振影像组学的乳腺癌病理信息预测模型研究[J]. 中国生物医学工程学报, 2020, 39(5): 513-523. DOI: 10.3969/j.issn.0258-8021.2020.05.001.
[14]	Rabasco P, Caivano R, Simeon V, et al. Can diffusion-weighted imaging and related apparent diffusion coefficient be a prognostic value in women with breast cancer?[J]. Cancer Invest, 2017, 35(2): 92-99. DOI: 10.1080/07357907.2016.1267740. pmid: 28107084
[15]	Girard A, Le Reste PJ, Metais A, et al. Combining ¹⁸F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study[J]. J Neurooncol, 2021, 155(3): 287-295. DOI: 10.1007/s11060-021-03873-w.
[16]	Prasanna P, Patel J, Partovi S, et al. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: preliminary findings[J]. Eur Radiol, 2017, 27(10): 4188-4197. DOI: 10.1007/s00330-016-4637-3. pmid: 27778090
[17]	Yang Y, Han Y, Zhao SJ, et al. Spatial heterogeneity of edema region uncovers survival-relevant habitat of glioblastoma[J]. Eur J Radiol, 2022, 154: 110423. DOI: 10.1016/j.ejrad.2022.110423.
[18]	Braman NM, Etesami M, Prasanna P, et al. Erratum to: intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI[J]. Breast Cancer Res, 2017, 19(1): 80. DOI: 10.1186/s13058-017-0862-1. pmid: 28693537
[19]	Xie CY, Yang PF, Zhang XB, et al. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy[J]. EBioMedicine, 2019, 44: 289-297. DOI: 10.1016/j.ebiom.2019.05.023. pmid: 31129097
[20]	Citrin DE. Recent developments in radiotherapy[J]. N Engl J Med, 2017, 377(11): 1065-1075. DOI: 10.1056/NEJMra1608986.
[21]	Deutsch E, Chargari C, Galluzzi L, et al. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy[J]. Lancet Oncol, 2019, 20(8): e452-e463. DOI: 10.1016/S1470-2045(19)30171-8.
[22]	John F, Bosnyák E, Robinette NL, et al. Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival[J]. Neuro Oncol, 2019, 21(2): 264-273. DOI: 10.1093/neuonc/noy169.
[23]	Parker JG, Servati M, Diller EE, et al. Targeting intra-tumoral heterogeneity of human brain tumors with in vivo imaging: a roadmap for imaging genomics from multiparametric MR signals[J]. Med Phys, 2023, 50(4): 2590-2606. DOI: 10.1002/mp.16059.
[24]	Shankar LK, Schöder H, Sharon E, et al. Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop[J]. Lancet Oncol, 2023, 24(3): e133-e143. DOI: 10.1016/S1470-2045(22)00742-2.
[25]	杨浩然, 马密密, 曹新山. 基于影像组学的肝细胞癌多中心研究进展[J]. 磁共振成像, 2021, 12(8): 101-103. DOI: 10.12015/issn.1674-8034.2021.08.023.
[26]	Bernatowicz K, Grussu F, Ligero M, et al. Robust imaging habitat computation using voxel-wise radiomics features[J]. Sci Rep, 2021, 11(1): 20133. DOI: 10.1038/s41598-021-99701-2. pmid: 34635786
[27]	Juan-Albarracín J, Fuster-Garcia E, Pérez-Girbés A, et al. Glioblastoma: vascular habitats detected at preoperative dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging predict survival[J]. Radiology, 2018, 287(3): 944-954. DOI: 10.1148/radiol.2017170845. pmid: 29357274
[28]	Syed AK, Whisenant JG, Barnes SL, et al. Multiparametric analysis of longitudinal quantitative MRI data to identify distinct tumor habitats in preclinical models of breast cancer[J]. Cancers (Basel), 2020, 12(6): 1682. DOI: 10.3390/cancers12061682.
[29]	Juan-Albarracín J, Fuster-Garcia E, García-Ferrando GA, et al. ONCOhabitats: a system for glioblastoma heterogeneity assessment through MRI[J]. Int J Med Inform, 2019, 128: 53-61. DOI: 10.1016/j.ijmedinf.2019.05.002. pmid: 31160012

生境分析在恶性肿瘤影像组学中的研究进展

Research progress of habitat analysis in radiomics of malignant tumors

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 29

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.